Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Study Details
Study Description
Brief Summary
The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
patients with acute leukemia (AML or ALL)
|
Other: assessments
Thus, a prospective observational study in which all newly diagnosed or newly relapsed acute leukemia patients would be registered close to the beginning of induction or re-induction therapy would allow us to follow patients throughout their journey and identify prospectively the reasons why patients did not proceed to HCT when deemed appropriate and eligible.
|
Outcome Measures
Primary Outcome Measures
- number of patients who proceed to transplant [3 years]
determine whether an individual patient proceeded to HCT when he or she was considered eligible (based on NCCN guidelines.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with newly diagnosed or relapsed acute leukemia. Patients undergoing reinduction due to primary induction failure are also eligible.
-
18 years of age or older and 75 years of age or younger, admitted for treatment on the Adult Leukemia Service.
Exclusion Criteria:
- Patients with relapsed acute leukemia post-allogeneic transplant
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hartford Healthcare Cancer Institute @ Hartford Hospital | Hartford | Connecticut | United States | 06102 |
2 | Memorial Sloan Kettering Cancer Center | New York | New York | United States | 10065 |
3 | Lehigh Valley Health Network | Allentown | Pennsylvania | United States | 18103 |
Sponsors and Collaborators
- Memorial Sloan Kettering Cancer Center
Investigators
- Principal Investigator: Boglarka Gyurkocza, MD, Memorial Sloan Kettering Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 16-024